首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

2076242

糖化白蛋白檢測市場：依產品類型、應用、最終用戶和地區分類

Glycated Albumin Assay Market, by Product Type, by Application, by End User, by Region

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

糖化白蛋白檢測市場預計到 2026 年將達到 7.222 億美元，預計到 2033 年將達到 12.621 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 8.3%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	7.222億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	8.30%	2033年市場規模預測：	12.621億美元

糖尿病是一種全球高發生率的慢性代謝性疾病。糖化血紅蛋白（A1C）是長期血糖監測的標準檢測方法，已被證實與糖尿病的慢性併發症有關。然而，在可能影響血紅素代謝的臨床情況下，不建議進行A1C檢測。

糖化白蛋白 (GA) 檢測能夠反映短期血糖值，且不受會影響糖化血紅蛋白 (A1C) 水平的因素干擾。糖化白蛋白是果糖胺高度糖基化的部分。它採用標準化的酵素法調查方法，操作簡單快速。

市場動態

預計在預測期內，市場主要參與者透過收購等方式拓展產品系列等非內部成長策略的日益普及將推動市場成長。例如，2021年9月，全球領先的照護現場（POC）和中心檢查室醫療設備製造商EKF完成了對Advanced Diagnostic Laboratory LLC的收購。 Advanced Diagnostic Laboratory LLC是一家知名的檢測實驗室，專門為製藥、生物技術和醫療設備產業提供PCR檢測服務。

此外，市場主要參與者擴大採用內部成長策略，例如推出新產品以擴展產品系列，預計也將推動預測期內的市場成長。例如，2023年1月3日，領先的抗體和試劑供應商LifeSpan BioSciences Inc.推出了ELISA試劑盒LS-F15522，這是一款用於定量檢測血漿和血清樣本中人類糖化白蛋白的96孔盤酵素免疫分析法（ELISA）試劑盒。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數，介紹了全球糖化白蛋白檢測市場的主要公司概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份「全球Glico測量市場報告」旨在為該行業的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用各種策略矩陣來分析全球糖化白蛋白測量市場，從而簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Asahi Kasei Pharma Corporation
Weldon BIoTech, Inc.
Abbexa Ltd.
Laboratory Corporation of America
Biocompare
EFK Diagnostics
Elabscience BIoTechnology Inc.
Abbot
Diazyme Laboratories, Inc.
Abnova Corporation
BSBE
Maccura BIoTechnology Co.,Ltd.
LifeSpan BioSciences, Inc.
Biomatik
Geno Technology Inc.
AMS BIoTechnology（Europe）Limited
Epinex Diagnostics Inc
DxGen Corp

第9章

調查方法
關於本公司

簡介目錄

Product Code: CMI1915

Glycated Albumin Assay Market is estimated to be valued at USD 722.2 Mn in 2026 and is expected to reach USD 1,262.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 722.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.30%	2033 Value Projection:	USD 1,262.1 Mn

Diabetes mellitus is a chronic metabolic disease with a high incidence worldwide. Glycated hemoglobin (A1C) is the reference test for long-term glucose monitoring and has been shown to be associated with chronic complications of diabetes. However, A1C is not recommended in clinical situations that may affect hemoglobin metabolism.

The glycated albumin (GA) is a test that reflects short-term glycemia and is not influenced by situations that falsely alter A1C levels. Glycated albumin is the higher glycated portion of fructosamine. It is measured by a standardized enzymatic methodology, easy and fast to perform.

Market Dynamics

Increasing adoption of inorganic growth strategies, such as company acquisition by key players in the market to expand their product portfolio is expected to drive the market growth over the forecast period. For instance, in September 2021, EKF, a global medical manufacturer of Point-of-Care and Central Laboratory devices, completed the acquisition of Advanced Diagnostic Laboratory LLC, which is a well-known PCR-focused testing laboratory among the pharmaceutical, biotechnology and medical device communities.

The increasing adoption of organic growth strategies such as product launches by key players in the market to expand product portfolio is expected to drive the market growth over the forecast period. For instance, on 3 January 2023, LifeSpan BioSciences Inc, which is a leading provider of antibodies and reagents launched ELISA Kit-LS-F15522, which is a 96-well enzyme-linked immunosorbent assay (ELISA) for the Quantitative detection of human glycated albumin in samples of plasma and serum.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global glycated albumin assay market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study Asahi Kasei Pharma Corporation, Weldon Biotech, Inc., Abbexa Ltd., Laboratory Corporation of America, Biocompare, EFK Diagnostics, Elabscience Biotechnology Inc., Abbott, Diazyme Laboratories, Inc., Abnova Corporation, BSBE, Maccura Biotechnology Co.,Ltd., LifeSpan BioSciences, Inc., Biomatik, Geno Technology Inc., AMS Biotechnology (Europe) Limited, Epinex Diagnostics Inc., DxGen Corp.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global glycated albumin assay report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycated albumin assay market.

Detailed Segmentation:

Global Glycated albumin assay Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
Human Glycated Albumin Assay
Animal Glycated Albumin Assay
Global Glycated albumin assay Market, By Application (Revenue, USD Mn, 2021 - 2033)
Diagnostics
- Prediabetes
- Type 1 Diabetes
- Type 2 Diabetes
Research
Others
Global Glycated albumin assay Market, By End User (Revenue, USD Mn, 2021 - 2033)
Hospitals
Diagnostic Centers
Research Centers
Others
Global Glycated albumin assay Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Asahi Kasei Pharma Corporation*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Weldon Biotech, Inc.
Abbexa Ltd.
Laboratory Corporation of America
Biocompare
EFK Diagnostics
Elabscience Biotechnology Inc.
Abbott
Diazyme Laboratories, Inc.
Abnova Corporation
BSBE
Maccura Biotechnology Co.,
LifeSpan BioSciences, Inc.
Biomatik
Geno Technology Inc.
AMS Biotechnology (Europe) Limited
Epinex Diagnostics Inc
DxGen Corp

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
PORTER's Analysis
Pricing Analysis (2022)

4. Global Glycated Albumin Assay Market , By Product Type, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Human Glycated Albumin Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Animal Glycated Albumin Assay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Glycated Albumin Assay Market , By Application, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
  - Prediabetes
  - Type 1 Diabetes
  - Type 2 Diabetes
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Glycated Albumin Assay Market , By End User, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segments Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

7. Global Glycated Albumin Assay Market , By Region, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Asahi Kasei Pharma Corporation*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Weldon Biotech, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbexa Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Laboratory Corporation of America
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Biocompare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
EFK Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Elabscience Biotechnology Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbot
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Diazyme Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abnova Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BSBE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Maccura Biotechnology Co.,Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
LifeSpan BioSciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Biomatik
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Geno Technology Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AMS Biotechnology (Europe) Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Epinex Diagnostics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
DxGen Corp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies